Xiao-Dong Li

Xiao-Dong Li


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
YWYu-Peng Wu
Yu-Peng Wu
ZKZhi-Bin Ke
Zhi-Bin Ke
WZWen-Cai Zheng
Wen-Cai Zheng
YCYe-Hui Chen
Ye-Hui Chen
JZJun-Ming Zhu
Jun-Ming Zhu
NXNing Xu
Ning Xu
Expression of kinesin family member 18B (KIF18B), an ATPase with key roles in cell division, is deregulated in many cancers, but its involvement in prostate cancer (PCa) is unclear. Here, we investigated the expression and function of KIF18B in human PCa specimens and cell lines using bioinformatics analyses, immunohistochemical and immunofluorescence microscopy, and RT-qPCR and western blot analyses. KIF18B was overexpressed in PCa specimens compared with paracancerous tissues and was associated with poorer disease-free survival. In vitro, KIF18B knockdown in PCa cell lines promoted cell proliferation, migration, and invasion, and inhibited cell apoptosis, while KIF18B overexpression had the opposite effects. In a mouse xenograft model, KIF18B overexpression accelerated and promoted the growth of PCa tumors. Bioinformatics analysis of control and KIF18B-overexpressing PCa cells showed that genes involved in the PI3K–AKT–mTOR signaling pathway were significantly enriched among the differentially expressed genes. Consistent with this observation, we found that KIF18B overexpression activates the PI3K–AKT–mTOR signaling pathway in PCa cells both in vitro and in vivo. Collectively, our results suggest that KIF18B plays a crucial role in PCa via activation of the PI3K–AKT–mTOR signaling pathway, and raise the possibility that KIF18B could have utility as a novel biomarker for PCa.

3 April 2018 in BioMed Research International
Verified
Journal Article
Open access
PDF file
YWYong Wei
Yong Wei
YWYu-Peng Wu
Yu-Peng Wu
MLMin-Yi Lin
Min-Yi Lin
SCShao-Hao Chen
Shao-Hao Chen
YLYun-Zhi Lin
Yun-Zhi Lin
NXNing Xu
Ning Xu
Obesity is a known risk factor for prostate cancer progression and may contribute to poor treatment outcomes. However, little is known concerning the relationship between obesity (body mass index [BMI] ⩾ 30) and the urinary incontinence (UI) of patients after radical prostatectomy (RP). The goal of this study was to focus on the prevalence and duration of UI after RP with specific attention to the BMI. Subsequently, trials were identified in a literature search of PubMed, Embase, Cochrane Library, Web of Science, and Google Scholar using appropriate search terms. All comparative studies reporting BMI, study characteristics, and outcome data including the relationship between BMI and urinary incontinence data were included. Finally, four studies comprising 6 trials with 2890 participants were included. The results showed that obesity increased UI risk at 12 months in patients who underwent robotic-assisted laparoscopic radical prostatectomy (RLRP) (odds ratio [OR] 2.43, 95% confidence interval [CI] [1.21, 4.88], P=0.01). When stratified by the surgical methods, the pooled results showed that obesity increased UI risk at 24 months in patients who underwent RLRP (OR 2.00, 95% CI [1.57, 2.56], P<0.001). However, in patients who underwent laparoscopic radical prostatectomy (LRP), the pooled results showed that obesity does not increase UI risk at 24 months (OR 1.13, 95% CI [0.74, 1.72], P=0.58). This is the first study to include obesity as the primary independent variable. Outcomes indicate that obesity (BMI ≥ 30) may increase the UI risk at 12 and 24 months after RLRP. Well-designed randomized controlled trials with strict control of confounders are needed to make results comparable.

5 March 2018 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
NXNing Xu
Ning Xu
YWYu-Peng Wu
Yu-Peng Wu
DCDong-Ning Chen
Dong-Ning Chen
ZKZhi-Bin Ke
Zhi-Bin Ke
HCHai Cai
Hai Cai
XXXue-Yi Xue
Xue-Yi Xue

1 November 2008 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Open access
PDF file
AKAndrianos Kontogeorgis
Andrianos Kontogeorgis
XLXiao-Dong Li
Xiao-Dong Li
EKEunice Y. Kang
Eunice Y. Kang
JFJonathan E. Feig
Jonathan E. Feig
MPMarc Ponzio
Marc Ponzio
DGDavid E. Gutstein
David E. Gutstein
Gap junction redistribution and reduced expression, a phenomenon termed gap junction remodeling (GJR), is often seen in diseased hearts and may predispose toward arrhythmias. We have recently shown that short-term pacing in the mouse is associated with changes in connexin43 (Cx43) expression and localization but not with increased inducibility into sustained arrhythmias. We hypothesized that short-term pacing, if imposed on murine hearts with decreased Cx43 abundance, could serve as a model for evaluating the electrophysiological effects of GJR. We paced wild-type (normal Cx43 abundance) and heterozygous Cx43 knockout (Cx43+/−; 66% mean reduction in Cx43) mice for 6 h at 10–15% above their average sinus rate. We investigated the electrophysiological effects of pacing on the whole animal using programmed electrical stimulation and in isolated ventricular myocytes with patch-clamp studies. Cx43+/− myocytes had significantly shorter action potential durations (APD) and increased steady-state ( Iss) and inward rectifier ( IK1) potassium currents compared with those of wild-type littermate cells. In Cx43+/− hearts, pacing resulted in a significant prolongation of ventricular effective refractory period and APD and significant diminution of Iss compared with unpaced Cx43+/− hearts. However, these changes were not seen in paced wild-type mice. These data suggest that Cx43 abundance plays a critical role in regulating currents involved in myocardial repolarization and their response to pacing. Our study may aid in understanding how dyssynchronous activation of diseased, Cx43-deficient myocardial tissue can lead to electrophysiological changes, which may contribute to the worsened prognosis often associated with pacing in the failing heart.

1 January 2018 in Journal of Cancer
Verified
Journal Article
Open access
QZQing-Shui Zheng
Qing-Shui Zheng
SCShao-Hao Chen
Shao-Hao Chen
YWYu-Peng Wu
Yu-Peng Wu
HCHui-Jun Chen
Hui-Jun Chen
HCHong Chen
Hong Chen
NXNing Xu
Ning Xu
Purpose Paxillin regulates cell-cell adhesion, and altered Paxillin expression has been associated with human carcinogenesis. This study analyzed the association between Paxillin expression in prostate cancer (PCa) tissues with clinicopathological features, lymph node metastasis and biochemical PCa recurrence.

2 September 2015 in Applied Biochemistry and Biotechnology
Verified
Journal Article
Closed access
PDF file
DXDonglin Xia
Donglin Xia
Zisheng LuoZisheng Luo
Zisheng Luo
CCChao Chen
Chao Chen
YWYu-Fei Wang
Yu-Fei Wang
XLXiao-Dong Li
Xiao-Dong Li
HGHai-Ying Gu
Hai-Ying Gu